This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Laboratory and Clinical Observations

ROBERT C. ROSAN, M.D.; HARRY SHWACHMAN, M.D.; LUCAS L. KULCZYCKI, M.D.

Am J Dis Child. 1962;104(6):625-634.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

The increasing longevity of patients with cystic fibrosis of the pancreas is accompanied by an increasing incidence of complications not directly related to malabsorption or pulmonary disease. In this paper we point out that diabetes mellitus is such a complication, that it is commoner than previously reported, and that genetic liability to diabetes is of value in anticipating the disease, as it is in healthy children.

Patient Material

All patients were known to have cystic fibrosis of the pancreas and were seen through the facilities of Children's Hospital Medical Center. Diagnoses were confirmed by duodenal fluid assay and/or sweat electrolyte analysis. Ten patients with diabetes were known to us in an experience with about 1,300 patients with cystic fibrosis seen since 1947. The 1,300 patients represent approximately 880 families.

Definition of Diabetes

Our criterion for the diagnosis of diabetes was the presence of any 3 of the following findings: . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON

Harry Shwachman, M.D., The Children's Hospital, 300 Longwood Ave., Boston 15, Mass.; From the Division of Laboratories and Research and the Department of Medicine, Children's Hospital Medical Center, and the Department of Pediatrics, Harvard Medical School.

Footnotes
Submitted for publication June 29, 1961.

Supported in part by grant from United States Public Health Service Doctoral Fellowship (CF 9625) (Dr. Rosan).

Supported in part by grants from the Nutrition Foundation and from the National Institutes of Health (E-1560, CY-3335), United States Public Health Service.

Tolbutamide kindly supplied by Dr. C. J. O'Donovan, Upjohn Co.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?